TY - CONF T1 - The importance of adjusting for treatment crossover bias in oncology clinical trials: An analysis of the EGF104900 trial in metastatic breast cancer (mBC) JO - JOURNAL OF CLINICAL ONCOLOGY PY - 2013/05/20 AU - Paracha N AU - Davies A AU - Latimer N AU - Parker C AU - Mealing S AU - Scott D AU - Padhiar A AU - Schulpher M AU - Wang Q ED - VL - 31 IS - 15 Y2 - 2025/09/06 ER -